MA39227B1 - Amides hétéroaryles comme inhibiteurs de l'agrégation protéique - Google Patents
Amides hétéroaryles comme inhibiteurs de l'agrégation protéiqueInfo
- Publication number
- MA39227B1 MA39227B1 MA39227A MA39227A MA39227B1 MA 39227 B1 MA39227 B1 MA 39227B1 MA 39227 A MA39227 A MA 39227A MA 39227 A MA39227 A MA 39227A MA 39227 B1 MA39227 B1 MA 39227B1
- Authority
- MA
- Morocco
- Prior art keywords
- disease
- protein aggregation
- methods
- inhibitors
- parkinson
- Prior art date
Links
- 230000004845 protein aggregation Effects 0.000 title abstract 3
- -1 Heteroaryl amides Chemical class 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title 1
- 238000000034 method Methods 0.000 abstract 3
- 208000018737 Parkinson disease Diseases 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 206010003694 Atrophy Diseases 0.000 abstract 1
- 206010012289 Dementia Diseases 0.000 abstract 1
- 201000011240 Frontotemporal dementia Diseases 0.000 abstract 1
- 208000023105 Huntington disease Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 abstract 1
- 230000037444 atrophy Effects 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 201000001441 melanoma Diseases 0.000 abstract 1
- 230000004770 neurodegeneration Effects 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La présente invention concerne certains composés d'amide hétéroaryles, des compositions pharmaceutiques les contenant et des procédés d'utilisation associés, notamment des procédés permettant de prévenir, inverser, ralentir et inhiber l'agrégation protéique, et des procédés permettant de traiter des maladies qui sont associées à l'agrégation protéique, notamment les maladies neurodégénératives telles que la maladie de parkinson, la maladie d'alzheimer, la maladie du corps de lewy, la maladie de parkinson avec démence, la démence fronto-temporale, la maladie de huntington, la sclérose latérale amyotrophique et l'atrophie multisystématisée, et le cancer et le mélanome.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461933246P | 2014-01-29 | 2014-01-29 | |
| PCT/US2015/013263 WO2015116663A1 (fr) | 2014-01-29 | 2015-01-28 | Amides hétéroaryles comme inhibiteurs de l'agrégation protéique |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MA39227A1 MA39227A1 (fr) | 2017-09-29 |
| MA39227B1 true MA39227B1 (fr) | 2018-04-30 |
Family
ID=58698445
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA39227A MA39227B1 (fr) | 2014-01-29 | 2015-01-28 | Amides hétéroaryles comme inhibiteurs de l'agrégation protéique |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR099208A1 (fr) |
| MA (1) | MA39227B1 (fr) |
-
2015
- 2015-01-28 AR ARP150100239A patent/AR099208A1/es active IP Right Grant
- 2015-01-28 MA MA39227A patent/MA39227B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR099208A1 (es) | 2016-07-06 |
| MA39227A1 (fr) | 2017-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA202502749B (en) | Compositions and methods of inhibiting masp-3 for the treatment of various diseases and disorders | |
| PH12016501493A1 (en) | Heteroaryl amides as inhibitors of protein aggregation | |
| MA41013A (fr) | Compositions comprenant des souches bactériennes | |
| MX2018005600A (es) | Composiciones farmaceuticas y metodos para la inhibicion de indolamina 2,3-dioxigenasa e indicaciones para ello. | |
| MX2019007480A (es) | Anticuerpos monoclonales anti-alfa-sinucleina para prevenir la agregacion de tau. | |
| GEP20207151B (en) | Agents, Uses and Methods for the Treatment of Synucleinopathy | |
| MA40240A (fr) | Composés hétéroaryle d'inhibition de la kinase | |
| EA201991756A1 (ru) | Бисгетероарильные производные в качестве модуляторов агрегации белков | |
| PH12018500659A1 (en) | Compounds effective in treating hepatotoxicity and fatty liver diseases and uses thereof | |
| EA201991755A1 (ru) | Бициклические бисгетероарильные производные в качестве модуляторов агрегации белков | |
| MX2019003805A (es) | Activadores de flujo autofágico y fosfolipasa d y depuración de acumulaciones de proteína que incluyen tau y tratamiento de proteinopatías. | |
| MX2019004859A (es) | Tratamientos de combinacion que comprenden la administracion de imidazopirazinonas. | |
| MX2019001634A (es) | Compuestos amidas, composiciones farmacéuticas de estos y métodos para utilizarlos. | |
| ZA202003243B (en) | Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and neurodegenerative conditions | |
| EA201890460A1 (ru) | Композиции и способы лечения и предотвращения нейродегенеративных расстройств | |
| EP3773500A4 (fr) | Compositions et procédés de détection et de traitement de la maladie d'alzheimer | |
| MX2021005502A (es) | Composiciones y metodos para tratar enfermedades neurodegenerativas. | |
| EA201991753A1 (ru) | Алкоксибисгетероарильные производные в качестве модуляторов агрегации белков | |
| MX2019008603A (es) | Una composicion farmaceutica que comprende un derivado de oxazina y su uso en el tratamiento o la prevencion de la enfermedad de alzheimer. | |
| MA39227A1 (fr) | Amides hétéroaryles comme inhibiteurs de l'agrégation protéique |